Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class ASSE: 600276

"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Notice on Convening the 1st Extraordinary General Meeting in 2026

Sep 9, 2026 · Issued by Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange

Filed with SSE · Sep 9, 2026

Notice on Convening the 1st Extraordinary General Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A

"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Announcement on Progress in Repurchasing A-SharesSep 3
"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders of Unrestricted Shares Concerning A-Share RepurchaseAug 27
"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Announcement on Implementation Result of Shares Repurchase and Share ChangesAug 20
"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Indicative Announcement on Acceptance of Application for Drug Marketing AuthorizationJul 30

All Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A news releases